期刊文献+

酰腙氧钒(Ⅴ)配合物的合成、结构及其抑制幽门螺旋杆菌脲酶研究(英文) 被引量:1

Synthesis,Structures,and Helicobacter Pylori Urease Inhibition of Oxovanadium(Ⅴ) Complexes with Hydrazones
下载PDF
导出
摘要 本文合成了2个新的结构类似的酰腙氧钒(Ⅴ)配合物,[VOL(OCH3)(CH3OH)](L=L1=2-氯-N′-(5-氯-2-羟基苯亚甲基)苯甲酰肼(1);L=L2=2-氯-N′-(2-羟基-3-甲氧基苯亚甲基)苯甲酰肼(2)),并通过物理化学方法和单晶X-射线衍射表征了它们的结构。在每个配合物中,V原子都采取八面体配位构型,利用配体L中的3个给体原子和1个甲氧配体的氧原子定义其赤道面,利用1个酮氧原子和1个甲醇氧原子占据其2个轴向位置。本文还研究了这2个配合物对幽门螺旋杆菌脲酶的抑制活性。在浓度为100μmol.L-1时,配合物1和2对脲酶的抑制率分别为(82.0%±2.8%)和(28.2%±1.7%)。此外,还做了配合物和幽门螺旋杆菌脲酶的分子对接研究。 Two new structural similar oxovanadium(Ⅴ) complexes with the formulae [VOL(OCH3)(CH3OH)](L=L1= 2-chloro-N′-(5-chloro-2-hydroxybenzylidene)benzohydrazide(1);L=L2=2-chloro-N′-(2-hydroxy-3-methoxybenzyli-dene)benzohydrazide(2)),have been synthesized and characterized by physico-chemical methods and single-crystal X-ray diffraction.The V atom in each complex is in an octahedral coordination,with the three donor atoms of L and one methanolato O atom defining the equatorial plane,and with one oxo O atom and one methanol O atom occupying the axial positions.The complexes were evaluated for their urease inhibitory activities.The percent inhibition of the complexes 1 and 2 at the concentration of 100 μmol.L-1 on Helicobacter pylori urease are 82.0%±2.8% and 28.2%±1.7%.The molecular docking study of the complexes with the urease was performed.
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2012年第9期1959-1966,共8页 Chinese Journal of Inorganic Chemistry
基金 国家自然科学基金(No.20901036) 辽宁省高校优秀青年人才支持计划(No.LJQ2011114)资助项目
关键词 酰腙 钒氧(Ⅴ)配合物 晶体结构 脲酶 抑制剂 hydrazone oxovanadium(Ⅴ) complex crystal structure urease inhibitor
  • 相关文献

参考文献22

  • 1Francisco S S, Urrutia O, Martin V, et al. J. Sci. Food Agr., 2011,91:1569-1575.
  • 2Xiao Z P. Ma T W, Fu W C, et al. Eur. J. Med. Chem., 2010,45:5064-5070.
  • 3Barros T G, Williamson J S, Antunes O A C, et al. Lett. Drug Des. Discovery, 2009,6: ! 86-192.
  • 4Louie A Y, Meade T J. Chem. Rev., 1999,99:2711-2734.
  • 5Bernhardt P V, Chin P, Sharpe P C, et al. Dalton Trans., 2007,30:3232-3244.
  • 6Bernhardt P V, Wilson G J, Sharpe P C, et al. J. Biol. lnorg. Chem., 2008,13:107-119.
  • 7Yaul A R, Dhande V V, Suryawanshi N J, et al. Polish J. Chem.. 2009.83:565-571.
  • 8Willsky G R, Goldfine A B, Kostyniak P J, et al. J. Inorg. Biochem., 2001,85:33-42.
  • 9Orvig C, Caravan P, Gelmini L, et al. J. Am.. Chem. Soc., 1995,117:12759-12770.
  • 10Messerschmidt A, Prade L, Wever R. Biol. Chem., 1997, 378:309-315.

同被引文献27

  • 1Francisco S S;Urrutia O;Martin V.查看详情[J],Journal of the Science of Food and Agriculture20111569-1575.
  • 2Xiao Z P;Ma T W;Fu W C.查看详情[J],EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY20105064-5070.
  • 3Barros T G;Williamson J S;Antunes O A C.查看详情[J],LETTERS IN DRUG DESIGN & DISCOVERY2009186-192.
  • 4Louie A Y;Meade T J.查看详情[J],CHEMICAL REVIEWS19992711-2734.
  • 5Sumangala V;Poojary B;Chidananda N.查看详情[J],Medicinal Chemistry Research20132921-2928.
  • 6Tehrani K H M E;Sardari S;Mashayekhi V.查看详情[J],CHEMICAL AND PHARMACEUTICAL BULLETIN2013160-166.
  • 7Azizian J;Mohammadi M K;Firuzi O.查看详情[J],Medicinal Chemistry Research20123730-3740.
  • 8Willsky G R;Goldfine A B;Kostyniak P J.查看详情[J],Journal of Inorganic Biochemistry200133-42.
  • 9Orvig C;Caravan P;Gelmini L.查看详情[J],Journal of the American Chemical Society199512759-12770.
  • 10Messerschmidt A;Prade L;Wever R.查看详情[J],Biological Chemistry1997309-315.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部